These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8400327)

  • 1. Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer.
    Miller WR; Watson DM; Jack W; Chetty U; Elton RA
    Breast Cancer Res Treat; 1993; 26(1):89-94. PubMed ID: 8400327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP binding proteins and prognosis in breast cancer.
    Miller WR; Elton RA; Dixon JM; Chetty U; Watson DM
    Br J Cancer; 1990 Feb; 61(2):263-6. PubMed ID: 2155642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of prognostic factors in operable breast cancer.
    Hawkins RA; Tesdale AL; Killen ME; Jack WJ; Chetty U; Dixon JM; Hulme MJ; Prescott RJ; McIntyre MA; Miller WR
    Br J Cancer; 1996 Nov; 74(9):1469-78. PubMed ID: 8912547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer.
    Watson DM; Hawkins RA; Bundred NJ; Stewart HJ; Miller WR
    Br J Cancer; 1987 Aug; 56(2):141-2. PubMed ID: 2822069
    [No Abstract]   [Full Text] [Related]  

  • 5. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP binding proteins in human breast cancer.
    Miller WR; Senbanjo RO; Telford J; Watson DM
    Br J Cancer; 1985 Oct; 52(4):531-5. PubMed ID: 2998423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity.
    Senbanjo RO; Miller WR; Hawkins RA
    Br J Cancer; 1986 Jul; 54(1):127-30. PubMed ID: 3015182
    [No Abstract]   [Full Text] [Related]  

  • 8. The prognostic value of tumour-stroma ratio in triple-negative breast cancer.
    Moorman AM; Vink R; Heijmans HJ; van der Palen J; Kouwenhoven EA
    Eur J Surg Oncol; 2012 Apr; 38(4):307-13. PubMed ID: 22264965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma.
    Liu D; Baltayan A; Naritoku WY; Barr NJ; Young LL; Chaiwun B; Tsao-Wei DD; Groshen SL; Taylor CR; Torloni H; Neville AM; Cote RJ; Imam SA
    Anticancer Res; 2000; 20(3A):1451-61. PubMed ID: 10928056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
    Willner J; Kiricuta IC; Kölbl O
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer.
    Liu X; Feng C; Liu J; Zhao L; Liu J; Zhang W; Liu N; Niu Y
    Tumour Biol; 2016 Jun; 37(6):8027-36. PubMed ID: 26711786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival.
    Shabo I; Stål O; Olsson H; Doré S; Svanvik J
    Int J Cancer; 2008 Aug; 123(4):780-6. PubMed ID: 18506688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical outcome of receptor expression discordance between primary and metastatic breast cancer].
    Mu YX; Zhang P; Ma F; Yuan P; Wang JY; Xu BH; Li Q
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):506-511. PubMed ID: 30060358
    [No Abstract]   [Full Text] [Related]  

  • 14. Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
    Jahkola T; Toivonen T; Virtanen I; von Smitten K; Nordling S; von Boguslawski K; Haglund C; Nevanlinna H; Blomqvist C
    Br J Cancer; 1998 Dec; 78(11):1507-13. PubMed ID: 9836485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
    BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer.
    Sato K; Akimoto K
    Clin Breast Cancer; 2017 Jun; 17(3):e135-e142. PubMed ID: 27986439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEK: A novel early screening and prognostic marker for breast cancer.
    Ying G; Wu Y
    Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
    Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
    Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation.
    Turner BC; Gumbs AA; Carter D; Glazer PM; Haffty BG
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1169-76. PubMed ID: 10889369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.